IL10 and myeloid sarcoma: To determine which inflammatory stimulus modulates TG2 expression in monocytes, as might occur during MS, THP-1 monocytes were either untreated or treated with two pro-inflammatory stimuli, i.e., IL-1β or TNF-α or with two anti-inflammatory stimuli, i.e., IL-4 or IL-10.